Skip to content
- ANNX: Can Annexon Protect Vision? A Major Clinical Test Approaches
- ADAG: A Masked Cancer Treatment Moves Toward Its First Human Test
- RBBN: The Technology Behind New York’s Transit Communications Gets an Upgrade
- REBN: Beyond Coffee Shops, Reborn Targets Ready-to-Drink Retail Shelves
- AMRO: A New Nasdaq Arrival Bets on America’s Advanced-Manufacturing Supply Chain
- ATNM: Targeted Radiation Against Cancer Puts Actinium’s Research in Focus
- NAUT: Reading Proteins One Molecule at a Time Meets a Commercial Test
- CTSO: Can Blood Purification Reduce Dangerous Bleeding During Heart Surgery?
- EXYN: Autonomous Robots Go Underground in the Search for Critical Minerals
- IPW: iPower’s $21.9 Million AI Opportunity Needs a Signed Contract
